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Abstract
Background: Observational studies have reported associations between body mass index (BMI) and asthma, but
confounding and reverse causality remain plausible explanations. We aim to investigate evidence for a causal effect of BMI
on asthma using a Mendelian randomization approach.
Methods and Findings: We used Mendelian randomization to investigate causal effects of BMI, fat mass, and lean mass on
current asthma at age 7K y in the Avon Longitudinal Study of Parents and Children (ALSPAC). A weighted allele score
based on 32 independent BMI-related single nucleotide polymorphisms (SNPs) was derived from external data, and
associations with BMI, fat mass, lean mass, and asthma were estimated. We derived instrumental variable (IV) estimates of
causal risk ratios (RRs). 4,835 children had available data on BMI-associated SNPs, asthma, and BMI. The weighted allele score
was strongly associated with BMI, fat mass, and lean mass (all p-values,0.001) and with childhood asthma (RR 2.56, 95% CI
1.38–4.76 per unit score, p= 0.003). The estimated causal RR for the effect of BMI on asthma was 1.55 (95% CI 1.16–2.07) per
kg/m2, p= 0.003. This effect appeared stronger for non-atopic (1.90, 95% CI 1.19–3.03) than for atopic asthma (1.37, 95% CI
0.89–2.11) though there was little evidence of heterogeneity (p= 0.31). The estimated causal RRs for the effects of fat mass
and lean mass on asthma were 1.41 (95% CI 1.11–1.79) per 0.5 kg and 2.25 (95% CI 1.23–4.11) per kg, respectively. The
possibility of genetic pleiotropy could not be discounted completely; however, additional IV analyses using FTO variant
rs1558902 and the other BMI-related SNPs separately provided similar causal effects with wider confidence intervals. Loss of
follow-up was unlikely to bias the estimated effects.
Conclusions: Higher BMI increases the risk of asthma in mid-childhood. Higher BMI may have contributed to the increase in
asthma risk toward the end of the 20th century.
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Introduction
The prevalence of both obesity and asthma has increased in
children [1], leading to speculation that adiposity and asthma may
be causally related. Observational studies in children have
reported that obesity is positively associated with asthma [2,3],
and longitudinal studies have showed that obesity precedes
incident asthma [4,5]. Most such studies were based on body
mass index (BMI; weight [kg] divided by height squared [m2]), a
readily obtainable measure of body size that is essentially
independent of height. However, BMI is a relatively insensitive
indicator of adiposity compared with other measures, such as
percent body fat estimated by skinfold thickness [6]. BMI, which is
a composite of fat and lean mass, changes substantially with age
during childhood [7], and the proportion and distribution of body
fat differ between males and females with the same BMI [8].
Plausible explanations for a link between adiposity and asthma
include mediation through mechanical, immunological, or endo-
crine pathways; increased perception of symptoms; genetic
pleiotropy; and co-morbidity due to chronic inflammatory
mechanisms.
Whether observed associations arise from a causal effect of BMI
on asthma remains unclear, and the possibility of confounding by
common socio-economic, lifestyle, and dietary factors, or reverse
causality (for example, via children with asthma being more likely
to be sedentary), remains. The identification of genetic variants
related to BMI in recently reported genome-wide association
studies [9] provides an opportunity to examine the evidence for a
causal link, using the ‘‘Mendelian randomization’’ approach [10],
in which evidence for a causal link between a phenotype and a
disease outcome such as asthma is inferred from the associations of
genetic variants with the phenotype and with the disease outcome.
This approach should be unaffected by confounding or reverse
causation because genetic variants are generally unrelated to
confounding factors [11] and do not change after conception.
This study had three aims: (1) to investigate the association of
BMI, fat mass, and lean mass with childhood asthma in a large,
population-based birth cohort, (2) to use a Mendelian randomi-
zation approach based on single nucleotide polymorphisms (SNPs)
associated with adiposity to investigate evidence for a causal effect
of these phenotypes on asthma, and (3) to investigate whether the
magnitude of effect varies with gender or when asthma is classified
as atopic and non-atopic.
Methods
Cohort Description
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a longitudinal, population-based birth cohort study
that recruited 14,541 pregnant women resident in Avon, UK, with
an expected date of delivery from 1 April 1991 to 31 December
1992. There were 14,541 initial pregnancies for which the mother
enrolled in the ALSPAC study and either returned at least one
questionnaire or attended a ‘‘Children in Focus’’ clinic by 19 July
1999. For these initial pregnancies, there was a total of 14,676
fetuses, resulting in 14,062 live births and 13,988 children who
were alive at 1 y of age.
When the oldest children were approximately 7 y of age, an
attempt was made to bolster the initial sample with eligible cases
who had failed to join the study originally. The total sample size
for analyses using any data collected after the age of 7 y is
therefore 15,247 pregnancies, resulting in 15,458 fetuses. Of this
total sample of 15,458 fetuses, 14,775 were live births and 14,701
were alive at 1 y of age. The phases of enrollment are described in
more detail in the cohort profile paper [12]. The study website
(http://www.bris.ac.uk/alspac/researchers/data-access/data-
dictionary/) contains a fully searchable data dictionary with details
of all the available data.
Ethical approval was obtained from the ALSPAC Ethics and
Law Committee and local research ethics committees, and written
informed consent was obtained for all measurements.
Body Mass Index, Fat Mass, Lean Mass, and Asthma
Birth weight and length were measured by trained study staff or
obtained from hospital records, as described previously [13]. At
the ages of 7 to 9 y, children were invited to attend an annual
research clinic, during which anthropometric measures, including
height and weight, were taken [14]. Height was measured using a
Harpenden stadiometer (Holtain), and weight was measured using
Tanita TBF 305 scales (Tanita). BMI was calculated as weight (kg)
divided by height squared (m2). At age 9 y, in addition to standard
anthropometry, body composition (fat mass and lean mass) was
measured using a Lunar Prodigy dual X-ray emission absorpti-
ometry (DXA) scanner (GE Medical Systems Lunar) [15]. DXA
uses two X-ray beams of different energies that are attenuated to
different degrees as they pass through the body (according to the
quantity and nature of the tissue) to estimate fat mass, lean mass,
and bone mineral content. To adjust for differences in fat mass
between females and males, and to adjust for height, the measures
of fat mass and lean mass included in the analyses were calculated
as the residuals from a linear regression of each on gender, height,
and height squared. The standard deviation of fat mass residuals
was 4.35 kg, approximately double that of BMI (2.01 kg/m2) and
lean mass (1.71 kg) residuals. We divided the fat mass residuals by
two in subsequent analyses, so that regression coefficients for BMI,
fat mass, and lean mass that were of similar size reflected
associations of similar strength. International Obesity Task Force
[16] criteria were used to classify children as normal, overweight,
or obese at 7K y.
Current asthma at ages 7K, 11, and 14 y was defined based on
parental self-report of ever doctor diagnosis of asthma from
questionnaires sent to mothers at child ages 91, 128, and 166 mo,
respectively, together with either (1) reported asthma or symptoms
of wheezing in the previous 12 mo or (2) reported treatment for
asthma in the previous 12 mo. Current asthma at age 9 y was
defined based on parental report of asthma or symptoms of
wheezing or treatment for asthma in the previous 12 mo. Current
asthma at age 13 y was defined by parental report of asthma or
symptoms of wheezing in the previous 12 mo. Parental report of
ever doctor diagnosis of asthma at 15 y was also available. Atopic
status was determined at age 7K y by skin prick test response to a
panel of up to 12 common allergens including house dust mite,
grass pollen, cat, egg, peanut, and mixed nuts. A positive response
was defined as a mean weal diameter of .2 mm with an absent
response to negative control solution, and atopy was defined as a
positive response to one or more of house dust mite, grass pollen,
and cat. Atopic and non-atopic asthma were defined, respectively,
as current asthma with and without atopy at 7K y.
Confounders
From questionnaires sent to the mother during pregnancy we
obtained details of educational attainment (categorized into two
levels, with lower level defined as educated to school leaving
certificate at 16 y or lower) and smoking history. Sex of the child
and birth weight (categorized as low birth weight if ,2.5 kg) were
obtained from delivery health care records. A postnatal maternal
Effects of BMI on Asthma
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questionnaire at 8 mo after birth was used to ascertain environ-
mental tobacco smoke exposure.
Genetic Data
A total of 9,912 children were genotyped using the Illumina
HumanHap550Quad genome-wide SNP genotyping platform by
the Wellcome Trust Sanger Institute (Cambridge, UK) and
LabCorp (Burlington, North Carolina, US). Individuals were
excluded from further analysis on the basis of having incorrect
gender assignments, minimal or excessive heterozygosity (,0.320
or .0.345 for the Sanger data and ,0.310 or .0.330 for the
LabCorp data), disproportionate levels of individual missingness
(.3%), or evidence of cryptic relatedness (measured as proportion
of identity by descent .0.1). The remaining individuals were
assessed for evidence of population stratification by multidimen-
sional scaling analysis and compared with HapMap II (release 22)
European descent (CEU), Han Chinese, Japanese, and Yoruba
reference populations; all individuals with non-European ancestry
were removed to avoid population stratification; however, this step
removed very few individuals given the nature of the study, and as
a result had very little impact on the overall findings of the study.
SNPs with a minor allele frequency of ,1%, a call rate of ,95%,
or evidence for violations of Hardy-Weinberg equilibrium (p,
561027) were removed. Autosomal genotypic data were subse-
quently imputed using Markov Chain Haplotyping software
(MACH v.1.0.16) and phased haplotype data from CEU
individuals (HapMap release 22, Phase II NCBI B36, dbSNP
126) based on a cleaned dataset of 8,365 individuals and 500,527
autosomal SNPs. After imputation, all SNPs with indication of
poor imputation quality (r2,0.30) were removed.
A weighted allele score [17] was constructed from 32 SNPs
found to have genome-wide evidence for association with BMI and
adiposity in contemporary literature [9]. 21 of the 32 known BMI
variants used in our study were imputed, and the rest were
genotyped. These genotypes have previously been used in
ALSPAC as an instrumental variable (IV) [18–21]. The dosage
of the effect allele at each locus was multiplied by a SNP-specific
weight (linear coefficient divided by average of 32 linear
coefficients), then averaged across SNPs. SNP-specific weights
were based on a previously reported meta-analysis [9] that
excluded ALSPAC data. A weighted FTO dosage (using variant
rs1558902 from the FTO gene) and a weighted allele score derived
from the 31 other variants combined were also defined and used in
additional analyses.
Statistical Analysis
Analyses of associations of BMI, fat mass, and lean mass with
asthma were done using datasets restricted to children with
complete data on BMI at 7 y, asthma at 7K y, and each of the 32
selected SNPs, with multiple births and non-white individuals
excluded. Observational associations were further restricted to
children with data on confounders (gender, birth weight, pre- and
postnatal maternal exposure to smoking, maternal education) and
height at 9 y (for associations with fat mass and lean mass).
Logistic regression models were used to estimate per-allele odds
ratios (160 associations) for the individual associations between
each of the 32 SNPs and confounding factors (Table S1). Mean
differences for the association between all potential confounding
factors and BMI/fat mass/lean mass were estimated using linear
regression models. The linear coefficient for the association
Figure 1. Main Mendelian randomization features and results of the study. (A) depicts the IV assumptions, and (B) shows the two
unconfounded associations used to estimate causal effects of BMI on asthma: the association of the allele score with BMI and the association of the
allele score with asthma.
doi:10.1371/journal.pmed.1001669.g001
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between the confounding factors and the weighted allele score was
also estimated (Table S2).
Generalized linear models with binomial family and log link
were used to estimate risk ratios (RRs) for associations of BMI, fat
mass, and lean mass with asthma before and after adjusting for
confounders, and to estimate RRs for the association between the
weighted allele score and asthma. We also estimated these
associations after stratifying by atopic status and gender. Linear
regression models were used to estimate associations of the
weighted allele score with BMI, fat mass, and lean mass. All
analyses of BMI were stratified by gender. Likelihood ratio tests
were derived for interactions of estimated effects with gender, and
heterogeneity p-values for asthma subtype were derived using Chi-
squared tests.
We used two-stage IV methods [22], with genetic allele score as
IV, to estimate causal RRs for effects of BMI, fat mass, and lean
mass on asthma outcomes. Such methods exploit the IV
assumptions (Figure 1A) that allele score is (1) associated with
the phenotype (BMI), (2) independent of unmeasured confounders,
and (3) independent of the outcome given the phenotype and
unmeasured confounding factors. Estimation (Figure 1B) is based
on the associations (1) between allele score and BMI and (2)
between allele score and asthma, each of which is unconfounded
based on the IV assumptions. The first stage of estimation fits a
linear regression of the phenotype on the weighted allele score.
The second stage is a regression of the asthma outcome on the
phenotype values predicted by the first stage regression. To
adjust standard errors (SEs) to incorporate the uncertainty in the
first stage predicted phenotype values, estimation of both stages
was performed jointly within the generalized method of
moments (GMM) framework. We additionally estimated causal
RRs using multiplicative structural mean models (MSMMs)
(equivalent to the multiplicative generalized method of moments
[MGMM]) [22,23] with bootstrapped SEs. When performing
MSMM estimation, if the GMM estimation algorithm did not
converge, then we used the Newton-Raphson algorithm. In some
Table 1. Characteristics of 4,835 children with data on genetic markers, asthma, and BMI and risks of current asthma at 7K y.
Characteristic Number Non-Asthma/Asthmaa
Risk (95% CI) of
Current Asthma at
7K y
BMI (kg/m2) at 7 y{ 4,241/594
Normal 3,685/502 0.12 (0.11, 0.13)
Overweight 441/62 0.12 (0.09, 0.16)
Obese 115/30 0.21 (0.14, 0.31)
Fat mass (kg) at 9 y 3,586/500
#median residual fat mass 1,840/233 0.11 (0.10, 0.13)
.median residual fat mass 1,746/267 0.13 (0.12, 0.15)
Lean mass (kg) at 9 y` 3,586/500
#median residual lean mass 1,807/236 0.12 (0.10, 0.13)
.median residual lean mass 1,779/264 0.13 (0.11, 0.15)
Atopy at 7K y (skin prick test) 3,608/501
No 3,038/249 0.08 (0.07, 0.09)
Yes 570/252 0.31 (0.27, 0.35)
Gender 4,241/594
Male 2,107/352 0.14 (0.13, 0.16)
Female 2,134/242 0.10 (0.09, 0.12)
Low birth weight (,2,500 g) 4,191/587
No 4,067/569 0.12 (0.11, 0.13)
Yes 124/18 0.13 (0.08, 0.21)
Prenatal maternal smoking 4,188/589
No 3,175/428 0.12 (0.11, 0.13)
Yes 1,013/161 0.14 (0.12, 0.16)
Postnatal maternal smoking 4,054/555
No 3,368/450 0.12 (0.11, 0.13)
Yes 686/105 0.13 (0.11, 0.16)
Lower level maternal education* 4,157/582
No 1,927/264 0.12 (0.11, 0.14)
Yes 2,230/318 0.12 (0.11, 0.14)
aNumber of children with data available.
{BMI cut points for overweight and obese defined by Cole et al. [16].
`Median lean mass and median fat mass were calculated and used separately for females and males.
*Educated to General Certificate of Education level (school leaving certificate at 16 y) or lower.
doi:10.1371/journal.pmed.1001669.t001
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situations the MGMM/MSMM approach did not result in
unique solutions: these are indicated in Table S4. To examine
evidence of pleiotropy we derived a forest plot displaying IV
estimates (and 95% CIs) derived using individual SNPs
contributing to the allele score, and conducted overidentification
tests of differences between these SNP-based IV estimates. All
statistical analyses were performed using Stata v.13 (Stata
Corp).
Results
There were 4,835 children (594 [12.3%] with asthma) in whom
the presence/absence of current asthma at 7K y, BMI at 7 y, and
data on the 32 BMI-related SNPs were recorded. 4,086 of these
children also had complete data on fat mass and lean mass at 9 y.
Table 1 shows characteristics of these children and the risks of
current asthma at 7K y. Mean BMI (16.2 kg/m2, SE= 2.0), fat
mass (8.4 kg, SE= 4.9), and lean mass (24.5 kg, SE= 3.1)
appeared similar in children with and without asthma, although
mean BMI was higher in girls with (16.7 kg/m2) than without
(16.2 kg/m2) asthma. The prevalence of atopy was much higher in
children with (252 [50.3%]) than without (570 [15.8%]) asthma.
The prevalence of maternal prenatal smoking was somewhat
higher in children with asthma (161 [27.3%]) than without (1,013
[24.2%]), and similarly for postnatal maternal smoking (105
[18.9%] versus 686 [16.9%]). The risk of current asthma at 7K y
appeared higher for children categorized as obese (risk 0.21, 95%
CI 0.14–0.31), atopic (0.31, 95% CI 0.27–0.35), and male (0.14,
95% CI 0.13–0.16). Children excluded from analyses because of
missing data tended to have lower birth weight, and their mothers
tended to have lower educational attainment and to smoke during
and after pregnancy, compared with children included in the
analyses (Table 2).
Associations of BMI, Fat Mass, and Lean Mass with
Current Asthma
Data on BMI-related SNPs, current asthma at 7K y, and
confounders were complete for 4,467 children with data on BMI
at 7 y and for 3,812 children with data on fat mass, lean mass, and
height at 9 y. Table 3 shows associations of BMI, fat mass, and
lean mass with current asthma at 7K and 9 y before and after
stratification by gender. BMI, fat mass, and lean mass were
associated with current asthma at 7K y (adjusted RR for BMI
1.04 [95% CI 1.00–1.08] per kg/m2; fat mass 1.06 [95% CI 1.02–
1.10] per 0.5 kg; lean mass 1.06 [95% CI 1.00–1.11] per kg). Fat
mass was also associated with current asthma at 9 y (1.03 [95% CI
1.00–1.07] per 0.5 kg). Associations with BMI and lean mass
appeared stronger in females than males when using current
asthma at 7K y (1.08 [95% CI 1.03–1.14] versus 0.99 [95% CI
0.94–1.05], interaction p=0.02, for BMI; 1.11 [95% CI 1.03–
1.20] versus 1.01 [95% CI 0.94–1.08], interaction p=0.04, for
lean mass), and for BMI and fat mass when using current asthma
at 9 y (1.06 [95% CI 1.01–1.11] versus 0.96 [95% CI 0.91–1.01],
interaction p=0.005, for BMI; 1.07 [95% CI 1.02–1.13] versus
1.00 [95% CI 0.96–1.05], interaction p=0.04, for fat mass). There
was little evidence that the association of fat mass with current
asthma at 7K y and the association of lean mass with current
asthma at 9 y differed between boys and girls (interaction p=0.37
and 0.29, respectively).
Adjusted associations with BMI, fat mass, and lean mass
appeared stronger for non-atopic than for atopic current asthma at
7K y (1.08 [95% CI 1.02–1.14] versus 0.98 [95% CI 0.92–1.05],
heterogeneity p=0.03, for BMI; 1.09 [95% CI 1.03–1.15] versus
1.01 [95% CI 0.95–1.07], heterogeneity p=0.06, for fat mass;
1.14 [95% CI 1.05–1.24] versus 0.98 [95% CI 0.90–1.06],
heterogeneity p=0.01, for lean mass). Smaller evidence of
heterogeneity was found when using current asthma at 9 y
(p=0.06 for BMI, 0.10 for fat mass, and 0.08 for lean mass).
Table S1 shows allele frequencies and associations of individual
SNPs with BMI, fat mass, lean mass, and current asthma at age
7K y. The strongest associations were for rs571312 (near the
MC4R gene) (regression coefficient 0.20 kg/m2 per allele [95% CI
0.10–0.29] for BMI; 0.25 0.5 kg per allele [95% CI 0.13–0.36] for
fat mass; 0.12 kg per allele [95% CI 0.04–0.21] for lean mass).
There was little evidence for associations of individual SNPs with
asthma.
Associations of Weighted Allele Score with BMI, Fat Mass,
Lean Mass, and Current Asthma
Table 4 shows that the weighted allele score was strongly
associated with BMI (regression coefficient 2.22 [95% CI 1.76–
2.67] kg/m2 per unit score, p,0.001), fat mass (2.88 [95% CI
2.35–3.42] 0.5 kg per unit, p,0.001), lean mass (1.22 [95% CI
0.80–1.64] kg per unit, p,0.001), current asthma at 7K y (RR
2.56 [95% CI 1.38–4.76] per unit, p=0.003), and current asthma
at 9 y (RR 1.98 [95% CI 1.13–3.46] per unit, p=0.02). The
weighted allele score appeared more strongly associated with non-
atopic than atopic asthma (RR 3.92 [95% CI 1.45–10.59] per unit
versus 1.93 [95% CI 0.72–5.21] at 7K y; 2.26 [95% CI 0.89–
Table 2. Comparing participants included and excluded in these analyses.
Characteristic Included (n=4,835) Excluded (n=9,227)
p-Value* Comparing Included and
Excluded
n (%) female 2,376 (49.1%) 4,414 (47.9%) 0.145
Mean [SD] height (m) at 9 y 1.39 [0.06] 1.40 [0.06] 0.54
n (%) low birth weight (,2,500 g) 142 (3.0%) 661 (7.3%) ,0.001
n (%) lower level of maternal education** 2,548 (53.8%) 5,517 (71.4%) ,0.001
n (%) prenatal maternal smoking 1,174 (24.6%) 3,319 (39.2%) ,0.001
n (%) postnatal maternal smoking 791 (17.2%) 1,927 (29.1%) ,0.001
Of the 14,062 participants, 8,365 had genetic data (after genetic quality control filters excluding individuals with incorrect sex assignments, minimal or excessive
heterozygosity, disproportionate levels of missingness, cryptic relatedness, and non-European ancestry). 4,835 individuals had both genetic data and data on BMI and
current asthma at 7–7K y, and these individuals form the core sample for these analyses.
*Chi-squared tests and t-test were used as appropriate.
**General Certificate of Education level (school leaving certificate at 16 y) or lower, compared with A-level (qualification at 18 y) or degree level.
doi:10.1371/journal.pmed.1001669.t002
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5.69] versus 1.49 [95% CI 0.61–3.66] at 9 y), though there was
little evidence of heterogeneity (p=0.32 and 0.52, respectively).
We found little evidence that the weighted allele score was
associated with atopy (RR 0.82 [95% CI 0.50–1.63] per unit,
p=0.45).
Figure 2 (left panel) shows that there was a clear linear trend of
mean BMI across groups defined by quintiles of genotype-
predicted BMI. The right panel of Figure 2 shows the same data
superimposed on the overall distribution of BMI: although there is
extremely strong evidence of association, genotype explains only
2.1% of the between-child variability in BMI. As expected, we
found little evidence of associations between the five confounding
variables and the 32 selected SNPs (Table S2) or the weighted
allele score (Table S3).
Instrumental Variable Estimates of Causal Effects of BMI,
Fat Mass, and Lean Mass on Current Asthma
Table 5 shows the estimated RRs for the effects of BMI, fat
mass, and lean mass on current asthma and asthma subtypes,
derived by using the weighted allele score as IV and using
Table 3. Associations of BMI, fat mass, and lean mass with current asthma, non-atopic asthma, and atopic asthma in children at
7K and 9 y.
Exposure
Number Non-Asthma/Asthma/Non-
Atopic Asthma/Atopic Asthma Adjusted
{ RR (95% CI)
Heterogeneity
p-Valueb
Current Asthma
Non-Atopic
Asthmaa Atopic Asthmaa
At 7K ya
BMI (kg/m2) at 7 y 3,928/539/216/239 1.04 (1.00, 1.08) 1.08 (1.02, 1.14) 0.98 (0.92, 1.05) 0.03
Males 1,942/315/114/147 0.99 (0.94, 1.05) 1.06 (0.96, 1.16) 0.91 (0.83, 1.01)
Females 1,986/224/102/92 1.08 (1.03, 1.14) 1.09 (1.01, 1.18) 1.06 (0.97, 1.16)
p-Value for gender
interaction`
0.02 0.46 0.04
Fat mass (kg/2) at
9 y*
3,352/460/186/206 1.06 (1.02, 1.10) 1.09 (1.03, 1.15) 1.01 (0.95, 1.07) 0.06
Males 1,634/262/96/124 1.04 (0.99, 1.10) 1.07 (0.99, 1.17) 1.00 (0.92, 1.08)
Females 1,718/198/90/82 1.07 (1.02, 1.13) 1.10 (1.02, 1.19) 1.02 (0.92, 1.12)
p-Value for gender
interaction`
0.37 0.60 0.72
Lean mass (kg) at 9 y* 3,352/460/186/206 1.06 (1.00, 1.11) 1.14 (1.05, 1.24) 0.98 (0.90, 1.06) 0.01
Males 1,634/262/96/124 1.01 (0.94, 1.08) 1.09 (0.97, 1.23) 0.94 (0.85, 1.05)
Females 1,718/198/90/82 1.11 (1.03, 1.20) 1.19 (1.07, 1.33) 1.03 (0.90, 1.16)
p-Value for gender
interaction`
0.04 0.25 0.32
At 9 yc
BMI (kg/m2) at 7 y 3,377/644/257/283 1.01 (0.98, 1.05) 1.05 (0.99, 1.11) 0.96 (0.91, 1.03) 0.06
Males 1,656/374/130/180 0.96 (0.91, 1.01) 1.02 (0.94, 1.12) 0.88 (0.81, 0.97)
Females 1,721/270/127/103 1.06 (1.01, 1.11) 1.06 (0.98, 1.14) 1.06 (0.98, 1.16)
p-Value for gender
interaction`
0.005 0.41 0.005
Fat mass (kg/2) at
9 y*
2,952/558/222/253 1.03 (1.00, 1.07) 1.06 (1.01, 1.12) 1.00 (0.94, 1.06) 0.10
Males 1,429/319/111/160 1.00 (0.96, 1.05) 1.04 (0.96, 1.13) 0.97 (0.90, 1.04)
Females 1,523/239/111/93 1.07 (1.02, 1.13) 1.09 (1.01, 1.17) 1.05 (0.96, 1.14)
p-Value for gender
interaction`
0.04 0.29 0.18
Lean mass (kg) at 9 y* 2,952/558/222/253 1.03 (0.99, 1.08) 1.09 (1.01, 1.17) 0.99 (0.92, 1.07) 0.08
Males 1,429/319/111/160 1.01 (0.95, 1.07) 1.07 (0.96, 1.20) 0.96 (0.87, 1.05)
Females 1,523/239/111/93 1.06 (0.99, 1.13) 1.10 (0.99, 1.22) 1.03 (0.92, 1.16)
p-Value for gender
interaction`
0.29 0.65 0.37
{Adjusted for gender, birth weight, pre- and postnatal maternal exposure to smoking, and maternal education.
aControls were children with no current asthma at 7K y.
bChi-squared test comparing estimate effects for non-atopic and atopic asthma.
`Test for the null hypothesis that the RR in males is the same as the RR in females (likelihood ratio test).
*Based on residuals from regression models of mass measure (fat/lean mass) on height, height squared, and gender. Fat mass was divided by two so that its standard
deviation was similar to that of BMI and lean mass.
cControls were children with no current asthma at 9 y.
doi:10.1371/journal.pmed.1001669.t003
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two-stage GMM estimation. The estimated causal RRs for the
effects of BMI on current asthma at 7K and 9 y were 1.55 (95%
CI 1.16–2.07) and 1.38 (95% CI 1.06–1.80) per kg/m2,
respectively. At age 7K y this effect appeared greater for non-
atopic asthma (1.90 [95% CI 1.19–3.03]) than atopic asthma (1.37
[95% CI 0.89–2.11]), though there was little evidence of
heterogeneity (p=0.31). The effects of BMI on asthma at age
7K y appeared similar in girls (1.77 [95% CI 1.13–2.77]) and
boys (1.40 [95% CI 0.96–2.04]) (interaction p=0.43). Estimated
causal RRs for the effects of fat mass and lean mass on current
asthma at 9 y were 1.28 (95% CI 1.03–1.59) per 0.5 kg and 1.74
(95% CI 1.04–2.90) per kg, respectively, with little evidence for a
difference between non-atopic and atopic asthma (heterogeneity
p=0.65 and 0.58, respectively). The estimated RR for the effect of
BMI on asthma at 7K y was 1.83 (95% CI 0.77–4.39) when using
the FTO variant alone as an IV, and 1.50 (95% CI 1.10–2.04)
when using an allele score based on the other 31 SNPs. The forest
plot in Figure 3 shows that IV estimates derived using the
individual BMI-related SNPs were consistent with each other.
Overidentification tests of differences between these IV estimates
gave no evidence against the null hypothesis of the joint validity of
the multiple instruments (all p-values$0.44).
Using the MSMM/MGMM approach, the estimated RRs
were 2.34 (95% CI 1.30–4.24) per kg/m2 for the effect of BMI
on current asthma at 7K y, 1.75 (95% CI 1.19–2.55) per 0.5 kg
for fat mass, and 1.55 (95% CI 0.99–2.44) per kg for lean mass
(Table S4). However, we noted problems in estimation for some
effects, because of either lack of convergence or a double
solution.
Table 6 shows the observational and IV estimates of the effect of
BMI at 7 y on current asthma at ages 11 to 14 y and ever doctor-
diagnosed asthma at ages 7K to 15 y, also stratified by gender and
for non-atopic and atopic asthma. The results are consistent with a
positive causal effect of BMI on asthma that did not decrease
notably with increasing age, although the magnitudes of estimated
effects at some ages were smaller than for the primary outcomes at
ages 7 and 9 y reported in Table 5.
Discussion
Main Findings
Based on a large, population-based birth cohort study we
confirmed a positive association between BMI and asthma in
mid-childhood and, using Mendelian randomization analyses
based on 32 BMI-associated SNPs, found strong evidence that
this association arose from a causal effect of BMI on asthma. The
effect of BMI appeared stronger for non-atopic than atopic
asthma, though evidence for interaction was weak. We found
evidence that higher fat mass and lean mass increase the risk of
asthma in mid-childhood. Effects persisted to age 15 y.
As an illustration of the possible public health impact of these
findings, the prevalence of asthma in UK children was estimated
to increase from around 6% to over 20% between 1975 and 2000
[24]. Contemporaneous increases in the BMI of a sample of 11- to
12-y-old children in the UK [25] were 1.54 kg/m2 in boys and
1.62 kg/m2 in girls. If these increases also applied in younger
children, they could account for up to a doubling of asthma
prevalence (1.7-fold in boys [1.401.54] and 2.5-fold in girls
[1.771.62]) based on our IV estimates.
Results in the Context of the Existing Literature
Our results are consistent with reports from observational
studies of the association between BMI and asthma in children.
The strongest evidence has come from prospective cohort studies,
which have mostly found positive associations of BMI in childhood
with incident asthma, summarized in a recent systematic review
[26]. Similar associations between BMI and asthma have been
reported in adults, with effect sizes similar to our IV estimates [27].
The origins of this association are not well understood. A plausible
explanation is that obesity is associated with systemic inflamma-
Table 4. Associations of the weighted allele score with BMI at age 7 y, fat and lean mass at age 9 y, and current asthma at age 7K
and 9 y.
Outcome
Number of Children (Total or
Non-Asthma/Asthma)
Linear Regression Coefficient
or RR (95% CI), p-Value{
BMI (kg/m2) at 7 y 4,835 2.22 (1.76, 2.67), p= 2.3610221
Fat mass (kg/2) at 9 y* 4,086 2.88 (2.35, 3.42), p= 2.0610225
Lean mass (kg) at 9 y* 4,086 1.22 (0.80, 1.64), p= 1.661028
Current asthma at 7K ya 4,241/594 2.56 (1.38, 4.76), p= 0.003
Non-atopic asthmaa 4,241/249 3.92 (1.45, 10.59), p=0.007
Atopic asthmaa 4,241/252 1.93 (0.72, 5.21), p= 0.19
Heterogeneity p-valueb 0.32
Current asthma at 9 yc 3,597/701 1.98 (1.13, 3.46), p= 0.016
Non-atopic asthmac 3,597/286 2.26 (0.89, 5.69), p= 0.09
Atopic asthmac 3,597/300 1.49 (0.61, 3.66), p= 0.38
Heterogeneity p-valueb 0.52
Atopy at 7K y (skin prick test) 3,553/937 0.82 (0.50, 1.63), p= 0.45
{Linear regression coefficient, adjusted for gender. RR for number non-asthma/asthma and number non-atopic/atopic.
*Based on residuals from regression models of mass measure (fat/lean mass) on height, height squared, and gender. Fat mass was divided by two so that its standard
deviation was similar to that of BMI and lean mass.
aControls were children with no current asthma at 7K y.
bChi-squared test comparing estimate effects for non-atopic and atopic asthma.
cControls were children with no current asthma at 9 y.
doi:10.1371/journal.pmed.1001669.t004
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tion, which may give rise to airway inflammation and asthma.
There is evidence that adipocytes are a source of pro-inflamma-
tory cytokines [28] but little evidence that systemic inflammation
in obesity is directly associated with airway inflammation [29].
Another possible link would be through promotion of allergic
inflammation by adipokine effects on the immune system, but, like
us, others have reported stronger associations of obesity with non-
atopic asthma [30], and we found no evidence that obesity is
associated with atopy in mid-childhood. A specific asthma-obesity
phenotype has been suggested in both adults and children [31],
which may be associated with increased asthma severity. There is
evidence that obesity in established asthma is associated with poor
asthma control, increased exacerbations, and suboptimal response
to glucocorticoids [32]. Poor response to steroids may be
associated with neutrophil-predominant airway inflammation
[33], consistent with our finding of a stronger association with
non-atopic asthma.
Studies in adults (systematically reviewed by Beuther and
Sutherland [27]) have reported positive associations of overweight
and incident asthma, with increasing effects in obese compared
with overweight individuals. Consistent results are reported from
childhood studies that prospectively ascertained BMI and incident
asthma: two recent systematic reviews [26,34] have synthesized
these results. Chen et al. [34] analyzed six studies of prospective
cohorts of children aged 5–18 y that investigated associations of
BMI with asthma incidence, reporting increased odds of asthma
for overweight and obese children and a dose-dependent effect of
BMI. Chen et al. specifically addressed gender stratification and
reported a greater effect size in males than in females. Egan et al.
[26] identified six studies meeting inclusion criteria that had data
on BMI in children ,18 y and incident asthma at least 12 mo
after BMI was measured. There was evidence of a positive
association between overweight and asthma, but inconsistent
evidence of sexual dimorphism in this relationship, similar to the
findings in adult prospective studies. Our study did not provide
strong evidence for sex stratification of the association between
genetically predicted BMI and asthma. Inconsistent findings in the
literature could reflect differences in definitions and categorization
of exposures and outcome in different studies but may also relate
to the timing of studies in relation to other influences on body
composition, some of which, such as age at menarche, might
themselves be under genetic influence. For example, in the 1958
British National Child Development Study birth cohort, females
with early menarche were more likely to be overweight [35], and
although age at menarche did not explain the association of
obesity with asthma in this study, both early menarche and obesity
were independently associated with persistence of asthma symp-
toms in the Tucson Children’s Respiratory Study, which followed
Figure 2. Association of BMI at 7 y with predicted BMI using the weighted allele score. The left panel shows the mean BMI (with 95% CI) in
groups defined by quintiles of genotype-predicted BMI. The right panel shows the same means and confidence intervals superimposed on the overall
distribution of BMI plotted against genotype-predicted BMI.
doi:10.1371/journal.pmed.1001669.g002
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children through adolescence [36]. Therefore, influences on body
composition that are unrelated to genetic prediction of BMI could
account for between-sex differences in associations.
The majority of studies of body mass and asthma have focused
on obesity and the inflammatory mechanisms through which fat
mass could induce the development of asthma. We found evidence
that both higher fat mass and higher lean mass increase the risk of
asthma. Each was measured in kilograms, but the standard
deviation of fat mass residuals was more than twice that of lean
mass residuals, and so we expressed the relationship between fat
mass and asthma as per 0.5 kg. Therefore, the odds ratios for fat
mass and lean mass are not directly comparable: their public
health implications for asthma risk will depend on the extent to
which they are affected by interventions such as dietary change or
increased exercise. Interventions to reduce BMI in obese children
and adolescents have been multifaceted (diet and physical activity)
and aimed at preserving lean mass while reducing BMI and fat
mass. The effects of such interventions have been demonstrated in
randomized controlled trials [37,38]. Therefore, public health
interventions are likely to have a greater impact on fat mass than
lean mass, with consequent differences in the impact of these
interventions on absolute asthma risk.
For example, Kno¨pfli et al. [38] quantified the effects of a
multidisciplinary inpatient intervention on body composition in
130 severely obese children, and observed reductions of 4.8 kg/m2
in BMI, 8.2 kg in fat mass, and 2.8 kg in fat-free (lean) mass. Based
on the IV estimates in Table 5, corresponding RRs for asthma are
1.5524.8 = 0.12 for BMI (88% risk reduction), 1.41216.4 = 0.004 for
fat mass (99% risk reduction), and 2.2522.8 = 0.10 for lean mass
(90% risk reduction). Similarly, Parks et al. [37] quantified change
in body composition during a weight loss trial in 61 obese
adolescents, and the corresponding RRs for asthma based on our
IV estimates are 1.5523.2 = 0.24 for BMI (76% risk reduction),
1.41216.0 = 0.004 for fat mass (99% risk reduction), and
2.2522.2 = 0.17 for lean mass only among girls (83% risk reduction
only among girls).
There is some evidence that body composition influences
asthma other than through obesity-related inflammatory mecha-
nisms. In a cross-sectional analysis, Sood et al. [39] reported that
lean mass, particularly truncal lean mass, was a better predictor of
asthma than fat mass in females, suggesting an effect of ectopic fat
in muscle and viscera, possibly through ready release of
inflammatory mediators from these sources into the systemic
circulation [40]. A study of obese adults with asthma has reported
Table 5. Instrumental variable estimates of the causal effect of BMI on current asthma, non-atopic asthma, and atopic asthma in
children at age 7K and 9 y using two-stage GMM estimator.
Exposure
Number Non-Asthma/Asthma/Non-
Atopic Asthma/Atopic Asthma Two-Stage GMM RR (95% CI)
Heterogeneity
p-Valuea
Current Asthma
Non-Atopic
Asthma Atopic Asthma
At 7K yb
BMI (kg/m2) at 7 y 4,241/594/249/252 1.55 (1.16, 2.07),
p= 0.003
1.90 (1.19, 3.03),
p= 0.008
1.37 (0.89, 2.11),
p= 0.16
0.31
Males 2,107/352/133/158 1.40 (0.96, 2.04),
p= 0.08`
1.47 (0.78, 2.77),
p= 0.23`
1.25 (0.71, 2.20),
p= 0.43`
Females 2,134/242/116/94 1.77 (1.13, 2.77),
p= 0.01`
2.49 (1.22, 5.06),
p= 0.01`
1.54 (0.78, 3.02),
p= 0.21`
p-Value for gender
interaction
0.43 0.28 0.64
Fat mass (kg/2) at
9 y*
3,586/500/209/216 1.41 (1.11, 1.79),
p= 0.006
1.73 (1.17, 2.55),
p= 0.006
1.25 (0.86, 1.80),
p= 0.24
0.24
Lean mass (kg) at 9 y* 3,586/500/209/216 2.25 (1.23, 4.11),
p= 0.009
4.36 (1.40, 13.59),
p= 0.01
1.69 (0.70, 4.12),
p= 0.25
0.20
At 9 yb
BMI (kg/m2) at 7 y 3,597/701/286/300 1.38 (1.06, 1.80),
p= 0.02
1.44 (0.95, 2.18),
p= 0.09
1.20 (0.81, 1.78),
p= 0.36
0.53
Males 1,775/414/147/193 1.46 (1.00, 2.15),
p= 0.05`
1.38 (0.74, 2.59),
p= 0.31`
1.24 (0.74, 2.10),
p= 0.41`
Females 1,822/287/139/107 1.29 (0.89, 1.88),
p= 0.18`
1.50 (0.86, 2.62),
p= 0.16`
1.13 (0.62, 2.05),
p= 0.68`
p-Value for gender
interaction
0.65 0.85 0.82
Fat mass (kg/2) at
9 y*
3,133/602/244/267 1.28 (1.03, 1.59),
p= 0.03
1.33 (0.95, 1.87),
p= 0.10
1.19 (0.85, 1.65),
p= 0.32
0.65
Lean mass (kg) at 9 y* 3,133/602/244/267 1.74 (1.04, 2.90),
p= 0.03
2.05 (0.86, 4.92),
p= 0.11
1.48 (0.69, 3.18),
p= 0.32
0.58
aChi-squared test comparing estimate effects for non-atopic and atopic asthma.
bControls were children with no current asthma.
`Test for the null hypothesis that the RR in males is the same as the RR in females (likelihood ratio test).
*Based on residuals from regression models of mass measure (fat/lean mass) on height, height squared, and gender. Fat mass was divided by two so that its standard
deviation was similar to that of BMI and lean mass.
doi:10.1371/journal.pmed.1001669.t005
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sexual dimorphism and an association of lean mass with
neutrophilic airway inflammation in obese females with asthma
[41]. Further elucidation of these effects will require quantification
of both fat and lean mass, and their relative distribution, in future
studies—particularly intervention studies—of body mass and
asthma.
Strengths and Limitations
The association between BMI and asthma could be under-
pinned by shared heritability. Our analyses assumed that the
effects of BMI-related SNPs on asthma are mediated through their
effect on BMI, but we cannot discount the possibility of genetic
pleiotropy. Twin studies suggest that a proportion of the
covariation between obesity and asthma is explained by shared
genetic factors [42,43]. Genome-wide linkage studies have
identified overlapping regions of the genome associated with both
asthma and obesity [44], but no genetic variants associated with
obesity and asthma have been consistently identified [45,46]. It is
conceivable that part of the heritability is explained by non-coding
variation in DNA, such as methylation [47] or other epigenetic
effects. Causal effect estimates may have been inflated by
pleiotropy, but we found little evidence for this.
Mendelian randomization is a powerful approach to estimating
the causal effects of modifiable exposures on disease outcomes in
observational studies, because genetic variants do not change in
response to disease and are generally unrelated to confounding
factors. Our IV analyses used an allele score based on 32 SNPs
whose effect on BMI was estimated in large genome-wide
association studies independent of our dataset. Nonetheless,
known genetic variants explain only a small proportion of
Figure 3. Forest plot of the individual causal effects on current asthma at 7K y of 32 BMI-related SNPs. The SNPs are those previously
reported in a meta-analysis [9] that excluded ALSPAC data. rs2287019 and rs4771122 were omitted from the forest plot because IV RRs were not
estimable. Also rs10150332, rs10767664, rs10938397, rs1555543, rs206936, rs2112347, rs2287019, rs2890652, rs381029, rs4771122, rs4836133,
rs9816226, and rs987237 were excluded because the corresponding SE (of the log RR) was .2.
doi:10.1371/journal.pmed.1001669.g003
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population variation in BMI, so the IV analyses that underpin
Mendelian randomization studies may require large sample sizes.
We found larger RRs using genetically predicted BMI than using
observed BMI, which was based on a single measurement.
Differences between observational associations and causal effects
can arise through confounding, although we think such effects
would tend to bias observational associations upwards rather than
downwards. The most plausible explanation for the observational
association being smaller is that IV genetically predicted BMI
measures lifetime exposure: changes in BMI over time would likely
attenuate observed associations.
Strengths of this study include the large size of the cohort, the
availability of DNA for genotyping, the ability to classify asthma as
atopic or non-atopic based on skin prick testing, and the
Table 6. Observational and instrumental variable estimates of the effect of BMI on current asthma at ages 11 to 14 y and doctor-
diagnosed asthma at ages 7K to 15 y in boys and girls and stratified by atopy at 7K y.
Outcome Observational Estimates of BMI (kg/m
2) at 7 y on Outcome IV Estimates of BMI (kg/m2) at 7 y on Outcome
Number Non-Asthma/Asthma Adjusted{ RR (95% CI) Number Non-Asthma/Asthma
Two-Stage GMM
RR (95% CI)
Current asthma at
11 y*
2,987/591 0.99 (0.95, 1.03) 3,169/633 1.27 (0.96, 1.68)
Males 1,435/350 0.95 (0.90, 1.01) 1,523/378 1.21 (0.82, 1.76)
Females 1,552/241 1.04 (0.98, 1.10) 1,646/255 1.38 (0.91, 2.08)
Non-atopic asthma 2,987/224 1.01 (0.95, 1.08) 3,169/241 1.51 (0.93, 2.46)
Atopic asthma 2,987/267 0.95 (0.89, 1.01) 3,169/282 1.09 (0.72, 1.64)
Current asthma at
13 y*
3,151/515 1.01 (0.97, 1.05) 3,348/545 1.48 (1.07, 2.04)
Males 1,527/298 0.98 (0.92, 1.04) 1,628/317 1.20 (0.76, 1.90)
Females 1,624/217 1.05 (0.99, 1.11) 1,720/228 1.86 (1.18, 2.94)
Non-atopic asthma 3,151/203 1.04 (0.97, 1.11) 3,348/217 2.66 (1.47, 4.82)
Atopic asthma 3,151/227 0.94 (0.87, 1.01) 3,348/239 1.06 (0.67, 1.66)
Current asthma at
14 y*
2,728/537 0.97 (0.93, 1.02) 2,886/570 1.29 (0.92, 1.80)
Males 1,320/296 0.94 (0.88, 1.01) 1,392/318 1.36 (0.85, 2.19)
Females 1,408/241 1.00 (0.95, 1.06) 1,494/252 1.19 (0.74, 1.90)
Non-atopic asthma 2,728/213 0.99 (0.93, 1.06) 2,886/227 1.91 (1.07, 3.42)
Atopic asthma 2,728/235 0.95 (0.88, 1.02) 2,886/247 0.92 (0.57, 1.49)
Ever DDA at 7K y* 3,600/867 1.03 (1.00, 1.06) 3,877/958 1.43 (1.15, 1.78)
Males 1,769/488 0.99 (0.95, 1.04) 1,911/548 1.38 (1.03, 1.86)
Females 1,831/379 NA 1,966/410 1.47 (1.07, 2.03)
Non-atopic asthma 3,600/436 1.06 (1.02, 1.10) 3,877/494 1.78 (1.26, 2.50)
Atopic asthma 3,600/298 0.97 (0.91, 1.03) 3,877/315 1.29 (0.86, 1.93)
Ever DDA at 11 y 3,147/805 1.03 (1.00, 1.06) 3,342/867 1.40 (1.12, 1.75)
Males 1,530/469 0.99 (0.94, 1.03) 1,625/509 1.36 (0.99, 1.85)
Females 1,617/336 1.06 (1.02, 1.10) 1,717/358 1.45 (1.06, 2.00)
Non-atopic asthma 3,147/390 1.06 (1.02, 1.11) 3,342/426 1.83 (1.29, 2.60)
Atopic asthma 3,147/292 0.96 (0.90, 1.02) 3,342/305 1.17 (0.80, 1.72)
Ever DDA at 14 y 2,882/810 1.01 (0.98, 1.04) 3,047/868 1.36 (1.07, 1.72)
Males 1,406/445 0.98 (0.93, 1.02) 1,484/483 1.38 (1.00, 1.91)
Females 1,476/365 1.04 (1.00, 1.08) 1,563/385 1.32 (0.94, 1.84)
Non-atopic asthma 2,882/402 1.05 (1.00, 1.09) 3,047/435 1.83 (1.25, 2.66)
Atopic asthma 2,882/291 0.95 (0.89, 1.01) 3,047/306 1.05 (0.70, 1.59)
Ever DDA at 15 y 2,076/594 1.05 (1.02, 1.09) 2,214/635 1.43 (1.10, 1.84)
Males 985/304 1.02 (0.96, 1.07) 1,046/332 1.36 (0.92, 2.01)
Females 1,091/290 NA 1,168/303 1.48 (1.06, 2.07)
Non-atopic asthma 2,076/298 NA 2,214/324 1.68 (1.14, 2.46)
Atopic asthma 2,076/213 0.98 (0.91, 1.05) 2,214/223 1.25 (0.78, 1.99)
{Adjusted for gender, birth weight, pre- and postnatal maternal exposure to smoking, and maternal education.
*Derived using ever doctor-diagnosed asthma (available at 7K, 11, 14, and 15 y) and parent-reported current asthma or wheezing or treatment in last 12 mo.
DDA, doctor-diagnosed asthma; NA, not available.
doi:10.1371/journal.pmed.1001669.t006
Effects of BMI on Asthma
PLOS Medicine | www.plosmedicine.org 11 July 2014 | Volume 11 | Issue 7 | e1001669
availability of fat mass and lean mass measured using DXA: BMI
may not be a good proxy for body fatness in children [48]. We
used reported doctor-diagnosed asthma together with reported
symptoms or asthma treatment in the 12 mo prior to 7K y as the
primary outcome: we have previously found this to correlate with
other measures of asthma phenotype [49]. The long-term nature
of the cohort meant that we could repeat analyses for asthma up to
age 15 y. Substantial loss to follow-up is inevitable in long-term
cohort studies: the subset of participants analyzed in this study
represents less than half of the original cohort, and more socially
disadvantaged participants were more likely to be lost (Table 2).
We do not believe that loss to follow-up is likely to have biased the
estimated effects of BMI reported here, because missingness is
predominantly in the outcome variable and is unlikely to be
related to genotype [50].
Conclusion
In conclusion, possible environmental influences on the
development of asthma in childhood have been extensively
investigated in epidemiological studies, but few of these provide
strong evidence for causality. We used Mendelian randomization
based on a weighted allele score to estimate the effect of higher
BMI in mid-childhood in increasing the risk of childhood asthma.
This effect could help explain some of the increase in asthma risk
toward the end of the 20th century, although the continued rise in
obesity but with a slowing in the rise in asthma prevalence in some
countries implies that other non-BMI-related factors are also likely
to be important. Our study illustrates the potential utility of using
genetic instruments to investigate causal effects in observational
studies, which may act as a stimulus to targeted interventions.
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Editors’ Summary
Background. The global burden of asthma, a chronic (long-
term) condition caused by inflammation of the airways (the
tubes that carry air in and out of the lungs), has been rising
steadily over the past few decades. It is estimated that,
nowadays, 200–300 million adults and children worldwide
are affected by asthma. Although asthma can develop at any
age, it is often diagnosed in childhood—asthma is the most
common chronic disease in children. In people with asthma,
the airways can react very strongly to allergens such as
animal fur or to irritants such as cigarette smoke, becoming
narrower so that less air can enter the lungs. Exercise, cold
air, and infections can also trigger asthma attacks, which can
be fatal. The symptoms of asthma include wheezing,
coughing, chest tightness, and shortness of breath. Asthma
cannot be cured, but drugs can relieve its symptoms and
prevent acute asthma attacks.
Why Was This Study Done? We cannot halt the ongoing
rise in global asthma rates without understanding the
causes of asthma. Some experts think obesity may be one
cause of asthma. Obesity, like asthma, is increasingly
common, and observational studies (investigations that
ask whether individuals exposed to a suspected risk factor
for a condition develop that condition more often than
unexposed individuals) in children have reported that body
mass index (BMI, an indicator of body fat calculated by
dividing a person’s weight in kilograms by their height in
meters squared) is positively associated with asthma.
Observational studies cannot prove that obesity causes
asthma because of ‘‘confounding.’’ Overweight children
with asthma may share another unknown characteristic
(confounder) that actually causes both obesity and asthma.
Moreover, children with asthma may be less active than
unaffected children, so they become overweight (reverse
causality). Here, the researchers use ‘‘Mendelian randomi-
zation’’ to assess whether BMI has a causal effect on asthma.
In Mendelian randomization, causality is inferred from
associations between genetic variants that mimic the effect
of a modifiable risk factor and the outcome of interest.
Because gene variants are inherited randomly, they are not
prone to confounding and are free from reverse causation.
So, if a higher BMI leads to asthma, genetic variants
associated with increased BMI should be associated with an
increased risk of asthma.
What Did the Researchers Do and Find? The researchers
investigated causal effects of BMI, fat mass, and lean mass on
current asthma at age 7K years in 4,835 children enrolled in
the Avon Longitudinal Study of Parents and Children
(ALSPAC, a long-term health project that started in 1991).
They calculated an allele score for each child based on 32
BMI-related genetic variants, and estimated associations
between this score and BMI, fat mass and lean mass (both
measured using a special type of X-ray scanner; in children
BMI is not a good indicator of ‘‘fatness’’), and asthma. They
report that the allele score was strongly associated with BMI,
fat mass, and lean mass, and with childhood asthma. The
estimated causal relative risk (risk ratio) for the effect of BMI
on asthma was 1.55 per kg/m2. That is, the relative risk of
asthma increased by 55% for every extra unit of BMI. The
estimated causal relative risks for the effects of fat mass and
lean mass on asthma were 1.41 per 0.5 kg and 2.25 per kg,
respectively.
What Do These Findings Mean? These findings suggest
that a higher BMI increases the risk of asthma in mid-
childhood and that global increases in BMI toward the end of
the 20th century may have contributed to the global
increase in asthma that occurred at the same time. It is
possible that the observed association between BMI and
asthma reported in this study is underpinned by ‘‘genetic
pleiotropy’’ (a potential limitation of all Mendelian random-
ization analyses). That is, some of the genetic variants
included in the BMI allele score could conceivably also
increase the risk of asthma. Nevertheless, these findings
suggest that public health interventions designed to reduce
obesity may also help to limit the global rise in asthma.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001669.
N The US Centers for Disease Control and Prevention
provides information on asthma and on all aspects of
overweight and obesity (in English and Spanish)
N The World Health Organization provides information on
asthma and on obesity (in several languages)
N The UK National Health Service Choices website provides
information about asthma, about asthma in children, and
about obesity (including real stories)
N The Global Asthma Report 2011 is available
N The Global Initiative for Asthma released its updated
Global Strategy for Asthma Management and Prevention on
World Asthma Day 2014
N Information about the Avon Longitudinal Study of Parents
and Children is available
N MedlinePlus provides links to further information on
obesity in children, on asthma, and on asthma in
children (in English and Spanish
N Wikipedia has a page on Mendelian randomization (note:
Wikipedia is a free online encyclopedia that anyone can
edit; available in several languages)
Effects of BMI on Asthma
PLOS Medicine | www.plosmedicine.org 14 July 2014 | Volume 11 | Issue 7 | e1001669
